Skip to main content
. 2021 Mar 5;12(9):2550–2559. doi: 10.7150/jca.54576

Table 2.

Correlation between the expression of ERCC3 and clinicopathologic parameters in pancreatic cancer

Characteristics Total Expression of ERCC3 p value
Low High
Gender
Male 35 2 33 0.640a
Female 25 3 22
Age at surgery
<60 21 2 19 1.000a
≥60 39 3 36
Tumor extent
T1/2 8 3 5 0.035a
T3/4 36 2 34
Lymph node metastasis
N0 33 3 30 1.000a
N1 25 2 23
Distant metastasis
M0 56 4 52 0.301a
M1 4 1 3
Tumor max diameter (cm)
<4 21 2 19 1.000a
≥4 39 3 36
Histologic grade
G1-2 35 2 33 0.640a
G3 25 3 22
TNM stage
I/II 47 4 43 0.347a
III/IV 4 1 3

Data was not available (NA) for some cases: Tumor extent (NA = 16), Lymph node metastasis (NA = 2), TNM stage (NA = 9);

a, Fisher exact test;

Significant p-value is in bold.